GeminIQ Website Logo

Viewing PACB free

Subscribe for full history, 90+ metrics, screener, watchlist...

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
615664565559557810077180386
Short Term Investments
176220216242260285335393410485452382
Accounts Receivable Net Current
312935313232282932303730
Inventory Net
615149535454596669675768
Prepaid Expense And Other Assets Current
101311121215191717171715
Restricted Cash Current
000001110000
Assets Current
339370375394413445496584628677742882
Property Plant And Equipment Net
272424222325313235373640
Operating Lease Right Of Use Asset
404142434444161722313335
Restricted Cash And Cash Equivalents Noncurrent
222222222222
Intangible Assets Net Excluding Goodwill
131415161718390436443450457462
Goodwill
318318318318318318318369369462462464
Other Assets Noncurrent
1314999991010101313
Assets
7527827848038258611,2601,4501,5091,6701,7461,898
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
191421161514171217211516
Accrued Liabilities Current
303434292729231922224635
Contract With Customer Liability Current
161616161515141719171622
Operating Lease Liability Current
10011210111210109
Other Liabilities Current
212136317385
Liabilities Current
6965736360676660787395184
Business Combination Contingent Consideration Liab…
----------096
Contract With Customer Liability Noncurrent
344466656665
Business Combination Contingent Consideration Liab…
--0000192119192018
Operating Lease Liability Noncurrent
605957545250151720293234
Convertible Long Term Notes Payable
644644645645646646647893893893892892
Other Liabilities Noncurrent
880000111111
Liabilities
7857807797677647697549971,0171,0211,0451,135
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
2,7152,7062,7002,6902,6782,6662,6552,6032,5842,5662,5402,522
Accumulated Other Comprehensive Income Loss Net Of…
-1-0000002-1-00-2
Retained Earnings Accumulated Deficit
-2,748-2,704-2,695-2,655-2,617-2,575-2,149-2,151-2,091-1,917-1,839-1,757
Stockholders Equity
-3325366192507453493649701764
Liabilities And Stockholders Equity
7527827848038258611,2601,4501,5091,6701,7461,898
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
505050505050505050505050
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,000
Common Stock Shares Issued
311310302302300300294274272272268258
Shares Outstanding
311310302302300300294274272272268258

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20265.67%17.02%-3.55%---------
20253.64%45.45%20.91%3.97%-3.97%60.32%30.34%-0.56%44.94%-18.40%3.68%-31.29%
20244.07%-20.35%23.84%-13.84%10.06%11.32%-8.14%-9.95%-30.32%9.68%-9.68%-8.06%
2023------18.42%39.47%-8.73%-33.93%-72.17%-63.73%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.92
5.65
5.15
6.24
6.92
6.68
7.48
9.74
8.01
9.28
7.81
4.80
Quick Ratio
3.90
4.67
4.32
5.21
5.81
5.64
6.31
8.35
6.92
8.12
7.03
4.34
Working Capital
269.83M
304.16M
302.22M
331.03M
353.64M
378.32M
429.38M
524.24M
549.75M
604.07M
647.02M
698.34M
Leverage & Debt
Debt to Equity
-23.64
329.67
145.58
21.25
12.42
8.39
1.49
2.20
2.06
1.57
1.49
1.49
Interest Coverage TTM
-18.15
-19.16
-79.65
-83.51
-70.72
-71.01
-35.36
-28.74
-29.93
-22.72
-23.32
-23.16
Debt Ratio
1.04
1.00
0.99
0.96
0.93
0.89
0.60
0.69
0.67
0.61
0.60
0.60
Efficiency & Turnover
Asset Turnover TTM
0.15
0.14
0.11
0.10
0.10
0.09
0.08
0.07
0.08
0.08
0.08
0.09
Days Sales Outstanding TTM
100.88
96.47
99.62
94.92
101.00
99.96
101.97
95.18
78.96
76.96
71.12
57.32
Receivables Turnover TTM
3.62
3.78
3.66
3.85
3.61
3.65
3.58
3.83
4.62
4.74
5.13
6.37
Per Share Metrics
Diluted EPS TTM
-0.42
-0.42
-1.82
-1.67
-1.75
-2.22
-1.07
-1.44
-1.47
-1.10
-1.21
-1.21
Free Cash Flow Per Share TTM
-0.40
-0.38
-0.38
-0.42
-0.51
-0.61
-0.78
-0.88
-0.96
-0.92
-1.06
-1.07
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
50.55%
51.99%
39.68%
34.04%
28.55%
21.77%
32.48%
32.05%
34.24%
38.22%
37.13%
28.52%
Operating Profit Margin TTM
-116.07%
-115.51%
-480.12%
-577.06%
-591.08%
-726.48%
-413.20%
-356.16%
-327.36%
-228.46%
-235.27%
-197.03%
Net Profit Margin TTM
-114.62%
-111.43%
-473.63%
-436.58%
-450.32%
-581.39%
-269.93%
-343.44%
-306.77%
-208.97%
-215.76%
-182.34%
Growth Metrics
Net Revenue Growth (1Y)
-1.93%
1.99%
0.50%
0.50%
-10.44%
-20.37%
-19.26%
-32.28%
-10.69%
6.00%
10.80%
23.76%
Net Income Growth (1Y)
-75.04%
-80.45%
76.34%
27.75%
31.46%
121.54%
1.02%
27.54%
25.43%
-7.44%
-2.39%
3.31%
EPS Growth (1Y)
-75.88%
-81.02%
61.36%
15.89%
19.30%
101.18%
-6.66%
19.17%
15.16%
-16.90%
-13.58%
-8.79%
Valuation Metrics
P/E TTM
-3.97
-3.14
-1.03
-0.76
-0.71
-0.53
-1.62
-1.18
-0.93
-3.40
-8.11
-6.89
P/B TTM
-15.71
170.62
104.87
10.67
6.05
3.82
0.99
1.02
0.76
1.56
3.55
2.79
P/S TTM
4.55
3.50
4.86
3.34
3.18
3.10
4.38
4.04
2.86
7.12
17.50
12.56
Market Cap
521.90M
403.68M
560.92M
385.08M
372.20M
350.29M
502.31M
463.96M
373.17M
1.01B
2.49B
2.13B
Enterprise Value
1.10B
989.92M
1.14B
973.77M
962.00M
935.78M
1.09B
1.28B
1.16B
1.83B
3.20B
2.64B
Calculated Values
Free Cash Flow TTM
-123.60M
-116.38M
-114.10M
-126.43M
-153.89M
-179.70M
-213.82M
-241.14M
-260.90M
-249.17M
-268.02M
-273.90M
Net Debt
581.73M
586.24M
581.68M
588.69M
589.80M
585.49M
592.12M
812.94M
791.05M
815.90M
709.61M
506.35M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-04-01Sale
Owner: Gibson, James R Ii
Title: See Remarks
Shares: 88,185
Price/Share: $1.37
Value: $120,813.45
Shares Owned: 1,245,663
Relationship: Officer
Ownership: Direct
2026-03-03Sale
Owner: Henry, Christian O
Title: See Remarks
Shares: 12,497
Price/Share: $1.51
Value: $18,870.47
Shares Owned: 3,581,813
Relationship: Officer
Ownership: Direct
2026-03-03Sale
Owner: Van, Oene Mark
Title: See Remarks
Shares: 6,504
Price/Share: $1.51
Value: $9,821.04
Shares Owned: 2,243,634
Relationship: Officer
Ownership: Direct
2026-03-03Sale
Owner: Farmer, Michele
Title: See Remarks
Shares: 2,979
Price/Share: $1.51
Value: $4,498.29
Shares Owned: 305,948
Relationship: Officer
Ownership: Direct
2026-02-18Sale
Owner: Farmer, Michele
Title: See Remarks
Shares: 14,952
Price/Share: $1.63
Value: $24,371.76
Shares Owned: 219,092
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
60.59%
Inst. Shares: 185,287,288
Shares Outstanding: 305,819,000
2025-12-31
66.08%
Inst. Shares: 198,213,083
Shares Outstanding: 299,959,000
2025-09-30
61.25%
Inst. Shares: 184,262,293
Shares Outstanding: 300,844,000
2025-06-30
64.65%
Inst. Shares: 194,068,734
Shares Outstanding: 300,162,000
2025-03-31
73.61%
Inst. Shares: 218,512,209
Shares Outstanding: 296,858,000

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) — SEC Financial Statements & Analysis

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) is a laboratory analytical instruments company, incorporated in DE. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. trades on Nasdaq as: PACB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported a -1.93% year-over-year revenue growth, a Gross Profit Margin of 50.55% (TTM), a Debt-to-Equity ratio of -23.64x, a Price-to-Sales (P/S) ratio of 4.55x (TTM), a Price-to-Book (P/B) ratio of -15.71x (TTM), at a market cap of $521.90M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-1.93%
Gross Profit Margin TTM
50.55%
Debt To Equity
-23.64x
P/S TTM
4.55x
P/B TTM
-15.71x
Market Cap
$521.90M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. in?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) operates in the Laboratory Analytical Instruments industry.

What is PACB's market cap?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) has a market capitalization of $521.90M as of 2026-06-30.

What exchange does PACB trade on?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) trades on the Nasdaq.

Where is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. incorporated?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.